Eric Hyllengren

Eric Hyllengren

Financieel Directeur/CFO bij ATARA BIOTHERAPEUTICS, INC.

Vermogen: 451 970 $ op 30-04-2024

49 jaar
Consumer Services
Health Technology

Oorsprong van het eerstegraads netwerk van Eric Hyllengren

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Major 35

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Eric Hyllengren via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
AMGEN INC. Pharmaceuticals: Major

Beth Seidenberg

Carol Gallagher

Roy Baynes

Christopher Haqq

Kerry Beth Daly

Joseph Newell

Derrell Porter

Kristin Yarema

Private Equity Investor

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Public Communications Contact

Director/Board Member

Sales & Marketing

Corporate Officer/Principal

Biotechnology

Jill Henrich

Jakob Dupont

Dietmar Berger

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

Roy Baynes

Derrell Porter

Utpal Koppikar

Dan Maziasz

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Beth Seidenberg

Roy Baynes

Renu Vaish

Private Equity Investor

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Pharmaceuticals: Major

Matthew Fust

Kanya Rajangam

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Biotechnology

Jill Henrich

General Counsel

CITIGROUP INC. Major Banks

Joshua House

House Joshua

Corporate Officer/Principal

Private Equity Investor

Pharmaceuticals: Major

Ameet Mallik

Pascal Touchon

Corporate Officer/Principal

Corporate Officer/Principal

ONCOMED PHARMACEUTICALS INC Pharmaceuticals: Major

Jill Henrich

Jakob Dupont

General Counsel

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Renu Vaish

Amie Krause

Corporate Officer/Principal

Corporate Officer/Principal

NOVARTIS AG Pharmaceuticals: Major

Ameet Mallik

Charlene Banard

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Isaac E. Ciechanover

Christopher Haqq

Maria Grazia Roncarolo

Utpal Koppikar

Kristin Yarema

Joshua House

House Joshua

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Investment Managers

Beth Seidenberg

John F. McGrath

Isaac E. Ciechanover

Consultant / Advisor

Corporate Officer/Principal

Private Equity Investor

College/University

Joel Marcus

Dietmar Berger

Director/Board Member

Corporate Officer/Principal

MACROGENICS, INC. Pharmaceuticals: Major

William Heiden

Matthew Fust

Chairman

Director/Board Member

University of California, Los Angeles College/University

Joel Marcus

K. Murugan

Derrell Porter

Graduate Degree

Graduate Degree

Undergraduate Degree

Georgetown College College/University

K. Murugan

Undergraduate Degree

College/University

Ameet Mallik

Kanya Rajangam

Graduate Degree

Doctorate Degree

New York University College/University

Jakob Dupont

Graduate Degree

St. Mary's College of California College/University

Charlene Banard

Dan Maziasz

Masters Business Admin

Undergraduate Degree

University of Connecticut College/University

Jill Henrich

Undergraduate Degree

The University of California, San Francisco College/University

Christopher Haqq

Corporate Officer/Principal

Vassar College College/University

Jakob Dupont

Undergraduate Degree

Hospital/Nursing Management

Jakob Dupont

Corporate Officer/Principal

University of the Witwatersrand College/University

Roy Baynes

Doctorate Degree

PDL BIOPHARMA, INC. Biotechnology

Jill Henrich

General Counsel

Medical/Nursing Services

Roy Baynes

Renu Vaish

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Roy Baynes

Corporate Officer/Principal

Miscellaneous Commercial Services

Roy Baynes

Corporate Officer/Principal

Pharmaceuticals: Major

Beth Seidenberg

Roy Baynes

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

NATERA, INC. Medical Specialties

Roy Baynes

Director/Board Member

Hospital/Nursing Management

Roy Baynes

Corporate Officer/Principal

Weill Cornell Medical College College/University

Isaac E. Ciechanover

Jakob Dupont

Doctorate Degree

Doctorate Degree

Harvard Medical School College/University

Christopher Haqq

Doctorate Degree

Miscellaneous Commercial Services

Joel Marcus

Renu Vaish

Director/Board Member

Corporate Officer/Principal

Medical/Nursing Services

Derrell Porter

Kristin Yarema

Director/Board Member

Director/Board Member

Biotechnology

Carol Gallagher

Kanya Rajangam

Director/Board Member

Chief Tech/Sci/R&D Officer

TRAVERE THERAPEUTICS, INC. Pharmaceuticals: Major

Roy Baynes

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Ameet Mallik

Derrell Porter

Masters Business Admin

Masters Business Admin

Stanford Graduate School of Business College/University

John F. McGrath

Matthew Fust

Masters Business Admin

Masters Business Admin

MEREO BIOPHARMA GROUP PLC Biotechnology

Jill Henrich

General Counsel

Pharmaceuticals: Major

Roy Baynes

Director/Board Member

GOSSAMER BIO, INC. Pharmaceuticals: Major

Jakob Dupont

Chief Tech/Sci/R&D Officer

Packaged Software

Beth Seidenberg

Matthew Fust

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Roy Baynes

Chief Tech/Sci/R&D Officer

ACELYRIN, INC. Pharmaceuticals: Major

Beth Seidenberg

Mina Kim

Director/Board Member

Chief Executive Officer

Pharmaceuticals: Major

Christopher Haqq

Chief Tech/Sci/R&D Officer

Statistieken

Internationaal

Verenigde Staten 47
Zwitserland 2
Zuid-Afrika 2
Verenigd Koninkrijk 2
Duitsland 2

Sectoraal

Health Technology 23
Consumer Services 16
Commercial Services 6
Health Services 5
Finance 4

Operationeel

Director/Board Member 184
Corporate Officer/Principal 85
Independent Dir/Board Member 56
Undergraduate Degree 29
Chief Executive Officer 27
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU